The global cardiac AI monitoring and diagnostics market is expected to see significant growth in the next few years, driven by factors such as the expansion of wearable and IoT devices, increasing adoption of telemedicine and remote monitoring, and integration of big data analytics and predictive modeling. Major companies in this market include Abbott Laboratories, Medtronic plc, and Siemens Healthineers AG.